Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: Effects of age and postnatal dexamethasone

Biology of the Neonate

Volumn 76, Issue 5, 1999, Pages 266-273

  D'Angio, Carl T ^a,b   Maniscalco, William M ^a   Ryan, Rita M ^a   Avissar, Nelly E ^a   Basavegowda, Kumar ^a   Sinkin, Robert A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Golisano Childrens Hospital at Strong   (United States)

Author keywords

Angiogenesis factor; Bronchopulmonary dysplasia; Chronic lung disease; Dexamethasone; Glucocorticoids; Lung development; Premature infants; Pulmonary lavage; Vascular endothelial growth factor

Indexed keywords

DEXAMETHASONE; LUNG SURFACTANT; OXYGEN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GESTATIONAL AGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG DYSPLASIA; LUNG LAVAGE; MULTICENTER STUDY; NEWBORN; OXYGEN CONSUMPTION; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGE FACTORS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOPULMONARY DYSPLASIA; DEXAMETHASONE; DOUBLE-BLIND METHOD; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LEUKOCYTE COUNT; LUNG; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; PULMONARY VENTILATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032875511     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014168     Document Type: Article

References (26)

1. Burri PH, Dbaly J, Weibel ER: The postnatal growth of the rat lung. I. Morphometry. Anat Rec 1974;178: 711-730.
2. Wilson WL, Mullen M, Olley PM, Rabinovitch M: Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery. Pediatr Res 1985;19: 1059-1067.
3. Shaffer SG, O'Neill D, Bradt SK, Thibeault DW: Chronic vascular pulmonary dysplasia associated with neonatal hyperoxia exposure in the rat. Pediatr Res 1987;21:14-20.
4. Obara H, Pappas CT, Northway WH Jr, Bensch KG: Comparison of the effect of two-and six-week exposure to 80% and 100% oxygen on the lung of the newborn mouse: A quantitative SEM and TEM correlative study. Int J Radiat Oncol Biol Phys 1985;11:285-298.
5. Coalson JJ, Winter VT, Gerstmann DR, Idell S, King RJ, Delemos RA: Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am Rev Respir Dis 1992;145:872-881.
6. Hislop AA, Haworth SG: Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990;9:152-161.
7. Christou H, Yoshida A, Arthur V, Morita T, Kourembanas S: Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 1998;18:768-776.
8. Levy AP, Levy NS, Iliopoulos O, Jiang C, Kaplin WG Jr, Goldberg MA: Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene. Kidney Int 1997;51:575-578.
9. Maniscalco WM, Watkins RH, D'Angio CT, Ryan RM: Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 1997;16:557-567.
10. Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffe RB: In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: Implications for mode of action. J Clin Endocrinol Metab 1994;79:316-322.
11. Klekamp JG, Jarzecka K, Hoover RL, Summar ML, Redmond N, Perkett EA: Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone. Pediatr Res 1997;42:744-749.
12. Maniscalco WM, Watkins RH, Finkelstein JN, Campbell MH: Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury. Am J Respir Cell Mol Biol 1995;13: 377-386.
13. Watkins RH, D'Angio CT, Ryan RM, Maniscalco WM: Vascular endothelial growth factor (VEGF) mRNA splice variant expression in acute hyperoxic lung injury (abstract). Am J Respir Crit Care Med 1998;157:A207.
14. Sanders RJ, Cox C, Phelps DL, Sinkin RA: Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res 1994; 36:122-128.
15. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS: Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind controlled study. J Pediatr 1990;117:273-282.
16. Oshika E, Liu S, Ung LP, Singh G, Shinozuka H, Michalopoulos GK, Katyal SL: Glucocorticoid-induced effects on pattern formation and epithelial cell differentiation in early embryonic rat lungs. Pediatr Res 1998;43:305-314.
17. Finkenzeller G, Technau A, Marme D: Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Commun 1995;208:432-439.
18. Sinkin RA, Dwecks HS, Morgan MJ, Gallaher KJ, Cox C, Phelps DL, Group RCTS: Early intravenous dexamethasone (dex) for the prevention of BPD in surfactant-treated babies with RDS (abstract). Pediatr Res 1998;43:195A.
19. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM: Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82:527-532.
20. LoMonaco MB, Barber CM. Sinkin RA: Differential cytokine mRNA expression by neonatal pulmonary cells. Pediatr Res 1996;39:248-252.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
22. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG: Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986;60: 532-538.
23. Lassus P, Ristimaki A. Ylikorkala O, Viinikka L, Andersson S: Does vascular endothelial growth factor reduce chronic lung injury in the preterm infant? (abstract). Pediatr Res 1998;43:289A.
24. Eicher DJ, Wagner CL, Condon C: Vascular endothelial growth factor (VEGF) in present in human milk (abstract). Pediatr Res 1997;41: 82A.
25. Perkett EA, Cotton RB, Lappalainen U: Vascular endothelial growth factor (VEGF) increases in tracheobronchial aspirates from intubated low birth weight infants during the first 10 days of life (abstract). Pediatr Res 1998;43:293A.
26. Currie A, Vyas J, McDonald J, Field D, Kotecha S: The role of vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) in the development of chronic lung disease of prematurity (CLD). Am J Respir Crit Care Med 1998:157: A698.